# Affinity Asset Advisors, LLC: Form 13F holdings

An institutional investment manager in NEW YORK, NY. SEC CIK 1773195.

- Quarter ended: 2026-06-30
- Filed: 2026-08-13
- Reported value: $2.21bn
- Positions: 113 (113 lines in the filing's table; lines for the same security and option type are added together here)
- Compared with: the 13F for the quarter ended 2026-03-31
- Filing: https://www.sec.gov/Archives/edgar/data/1773195/000101143826000516/

## Holdings

As filed, largest first. Reported value is what the manager stated at the quarter end (Jun 30, 2026), in US dollars; it is filing data, not a price. Weight is the share of the total reported value.

| Issuer | Class | Reported value | Weight | Shares | Put or call | Change on the quarter before |
| --- | --- | ---: | ---: | ---: | --- | --- |
| ROIVANT SCIENCES LTD | SHS | $132.7m | 6.0% | 3,750,000 |  | Added +950,000 |
| APOGEE THERAPEUTICS INC | COM | $131.0m | 5.9% | 987,000 |  | Reduced −297,926 |
| [SPYRE THERAPEUTICS INC (SYRE)](/companies/syre.md) | COM NEW | $113.6m | 5.1% | 1,279,134 |  | Unchanged |
| [XENON PHARMACEUTICALS INC (XENE)](/companies/xene.md) | COM | $96.3m | 4.4% | 1,595,000 |  | Reduced −80,000 |
| [ERASCA INC (ERAS)](/companies/eras.md) | COM | $96.2m | 4.3% | 5,250,000 |  | Reduced −100,000 |
| [INSMED INC (INSM)](/companies/insm.md) | COM PAR $.01 | $69.3m | 3.1% | 650,000 |  | Added +170,000 |
| [PRAXIS PRECISION MEDICINES I (PRAX)](/companies/prax.md) | COM NEW | $61.9m | 2.8% | 185,000 |  | Added +15,000 |
| ALKERMES PLC | SHS | $58.9m | 2.7% | 1,125,000 |  | Reduced −225,000 |
| [ORUKA THERAPEUTICS INC (ORKA)](/companies/orka.md) | COM | $56.2m | 2.5% | 590,000 |  | Added +90,327 |
| [ANAPTYSBIO INC (ANAB)](/companies/anab.md) | COM | $55.8m | 2.5% | 826,109 |  | Reduced −113,891 |
| [AVALO THERAPEUTICS INC (AVTX)](/companies/avtx.md) | COM NEW | $53.6m | 2.4% | 2,900,000 |  | Added +1,559,160 |
| [CYTOKINETICS INC (CYTK)](/companies/cytk.md) | COM NEW | $46.9m | 2.1% | 550,000 |  | Reduced −150,483 |
| [REVOLUTION MEDICINES INC (RVMD)](/companies/rvmd.md) | COM | $46.8m | 2.1% | 250,000 |  | Added +150,000 |
| [ABIVAX SA (ABVX)](/companies/abvx.md) | SPONSORED ADS | $44.0m | 2.0% | 330,000 |  | Reduced −75,000 |
| [FIRST TRACKS BIOTHERAPEUTICS (TRAX)](/companies/trax.md) | ORD SHS | $40.9m | 1.8% | 2,032,012 |  | New +2,032,012 |
| [DIANTHUS THERAPEUTICS INC (DNTH)](/companies/dnth.md) | COM | $39.0m | 1.8% | 400,000 |  | Added +50,000 |
| [SUTRO BIOPHARMA INC (STRO)](/companies/stro.md) | COM SHS | $38.9m | 1.8% | 1,172,487 |  | Added +102,968 |
| [MODERNA INC (MRNA)](/companies/mrna.md) | COM | $35.0m | 1.6% | 500,000 | Put | New +500,000 |
| NUVALENT INC | COM | $34.0m | 1.5% | 275,000 |  | Reduced −25,000 |
| [TREVI THERAPEUTICS INC (TRVI)](/companies/trvi.md) | COM | $33.6m | 1.5% | 1,800,172 |  | Reduced −200,000 |
| [MODERNA INC (MRNA)](/companies/mrna.md) | COM | $33.3m | 1.5% | 475,000 | Call | Reduced −325,000 |
| ARK ETF TR | GENOMIC REV ETF | $31.5m | 1.4% | 750,000 | Call | New +750,000 |
| [OVID THERAPEUTICS INC (OVID)](/companies/ovid.md) | COM | $27.3m | 1.2% | 10,144,562 |  | Reduced −491,756 |
| [LEXEO THERAPEUTICS INC (LXEO)](/companies/lxeo.md) | COM | $27.0m | 1.2% | 5,807,611 |  | Added +757,400 |
| [CELLDEX THERAPEUTICS INC NEW (CLDX)](/companies/cldx.md) | COM NEW | $26.0m | 1.2% | 700,000 |  | Added +200,000 |
| [BELITE BIO INC (BLTE)](/companies/blte.md) | SPONSORED ADS | $25.4m | 1.1% | 165,000 |  | Added +100,000 |
| [ENLIVEN THERAPEUTICS INC (ELVN)](/companies/elvn.md) | COM | $25.4m | 1.1% | 500,000 |  | Reduced −86,904 |
| FORTE BIOSCIENCES INC | COM NEW | $24.3m | 1.1% | 1,145,391 |  | Added +133,501 |
| [ELI LILLY & CO (LLY)](/companies/lly.md) | COM | $24.0m | 1.1% | 20,000 | Call | New +20,000 |
| [NURIX THERAPEUTICS INC (NRIX)](/companies/nrix.md) | COM | $23.5m | 1.1% | 967,620 |  | Unchanged |
| [ALTO NEUROSCIENCE INC (ANRO)](/companies/anro.md) | COM SHS | $22.4m | 1.0% | 850,000 |  | Added +350,000 |
| [MADRIGAL PHARMACEUTICALS INC (MDGL)](/companies/mdgl.md) | COM | $21.5m | 1.0% | 40,000 |  | Reduced −15,000 |
| [PROTAGONIST THERAPEUTICS INC (PTGX)](/companies/ptgx.md) | COM | $21.1m | 1.0% | 172,125 |  | Unchanged |
| [MINERALYS THERAPEUTICS INC (MLYS)](/companies/mlys.md) | COM | $20.2m | 0.9% | 750,000 |  | Unchanged |
| [RELAY THERAPEUTICS INC (RLAY)](/companies/rlay.md) | COM | $19.6m | 0.9% | 1,050,000 |  | Added +650,000 |
| [SAGIMET BIOSCIENCES INC (SGMT)](/companies/sgmt.md) | COM SER A | $19.3m | 0.9% | 2,497,864 |  | Added +1,629,844 |
| [JADE BIOSCIENCES INC (JBIO)](/companies/jbio.md) | COM NEW | $18.7m | 0.8% | 840,350 |  | Added +200,394 |
| [COGENT BIOSCIENCES INC (COGT)](/companies/cogt.md) | COM | $17.4m | 0.8% | 450,000 |  | Reduced −300,000 |
| [TRAVERE THERAPEUTICS INC (TVTX)](/companies/tvtx.md) | COM | $17.0m | 0.8% | 300,000 |  | Unchanged |
| [CULLINAN THERAPEUTICS INC (CGEM)](/companies/cgem.md) | COM | $15.9m | 0.7% | 875,760 |  | Added +94,500 |
| [SAVARA INC (SVRA)](/companies/svra.md) | COM | $15.5m | 0.7% | 2,512,153 |  | Unchanged |
| [IDEAYA BIOSCIENCES INC (IDYA)](/companies/idya.md) | COM | $14.9m | 0.7% | 400,000 |  | New +400,000 |
| [PERSPECTIVE THERAPEUTICS INC (CATX)](/companies/catx.md) | COM NEW | $14.4m | 0.6% | 4,214,582 |  | Added +1,050,000 |
| [ODYSSEY THERAPEUTICS INC (ODTX)](/companies/odtx.md) | COMMON STOCK | $14.3m | 0.6% | 766,346 |  | New +766,346 |
| COGENT BIOSCIENCES INC | NOTE 1.625%11/1 | $13.7m | 0.6% | $11,000,000 principal |  | Added +4,000,000 |
| [OMEROS CORP (OMER)](/companies/omer.md) | COM | $13.4m | 0.6% | 1,411,300 | Put | New +1,411,300 |
| HELIX ACQUISITION CORP III | USD CL A ORD SHS | $13.3m | 0.6% | 1,250,000 |  | Unchanged |
| [EQUILLIUM INC (EQ)](/companies/eq.md) | COM | $13.1m | 0.6% | 4,100,000 |  | Added +2,873,690 |
| ALKERMES PLC | SHS | $13.1m | 0.6% | 250,000 | Call | New +250,000 |
| ESTABLISHMENT LABS HLDGS INC | COM | $12.7m | 0.6% | 148,013 |  | Added +48,013 |
| [CLIMB BIO INC (CLYM)](/companies/clym.md) | COM | $12.7m | 0.6% | 972,000 |  | Added +272,000 |
| TEVA PHARMACEUTICAL INDS LTD | SPONSORED ADS | $12.7m | 0.6% | 374,000 |  | Reduced −1,026,000 |
| [VERADERMICS INC (MANE)](/companies/mane.md) | COMMON STOCK | $12.3m | 0.6% | 100,000 |  | Added +30,000 |
| [ARROWHEAD PHARMACEUTICALS IN (ARWR)](/companies/arwr.md) | COM | $12.2m | 0.6% | 150,000 |  | Reduced −50,000 |
| OMEROS CORP | NOTE 9.500% 6/1 | $12.2m | 0.6% | $6,525,000 principal |  | Unchanged |
| [TAYSHA GENE THERAPIES INC (TSHA)](/companies/tsha.md) | COM SHS | $11.9m | 0.5% | 1,750,000 |  | Added +750,000 |
| DAMORA THERAPEUTICS INC | COM NEW | $11.1m | 0.5% | 425,000 |  | Reduced −25,000 |
| [EUPRAXIA PHARMACEUTICALS INC (EPRX)](/companies/eprx.md) | COM | $10.9m | 0.5% | 1,650,000 |  | Added +60,995 |
| [VERA THERAPEUTICS INC (VERA)](/companies/vera.md) | CL A | $10.7m | 0.5% | 250,000 |  | Unchanged |
| PROQR THRAPEUTICS N V | SHS EURO | $10.3m | 0.5% | 5,543,936 |  | Added +3,089,658 |
| NEWAMSTERDAM PHARMA COMPANY | ORDINARY SHARES | $9.3m | 0.4% | 275,000 |  | Unchanged |
| [KORRO BIO INC (KRRO)](/companies/krro.md) | COM | $9.3m | 0.4% | 706,904 |  | Unchanged |
| UNIQURE NV | SHS | $9.2m | 0.4% | 200,000 | Call | Reduced −100,000 |
| [ANTERIS TECHNOLOGIES GLOBAL (AVR)](/companies/avr.md) | COM | $9.0m | 0.4% | 912,397 |  | Unchanged |
| ZURA BIO LTD | CLASS A ORD SHS | $8.6m | 0.4% | 1,464,303 |  | Reduced −1,100,000 |
| UNIQURE NV | SHS | $8.1m | 0.4% | 175,000 |  | New +175,000 |
| ASCENDIS PHARMA A/S | ORD SHS | $8.0m | 0.4% | 30,000 |  | New +30,000 |
| [IBIO INC (IBIO)](/companies/ibio.md) | COM NEW | $7.0m | 0.3% | 4,007,881 |  | Added +900,681 |
| [GENERATE BIOMEDICINES INC (GENB)](/companies/genb.md) | COM SHS | $6.7m | 0.3% | 400,000 |  | Added +50,000 |
| [EVOMMUNE INC (EVMN)](/companies/evmn.md) | COM SHS | $6.6m | 0.3% | 500,100 | Put | New +500,100 |
| [TYRA BIOSCIENCES INC (TYRA)](/companies/tyra.md) | COM | $6.4m | 0.3% | 200,012 |  | Reduced −57,500 |
| SOL-GEL TECHNOLOGIES LTD | SHS NEW | $6.3m | 0.3% | 84,900 |  | Added +49,900 |
| [SAB BIOTHERAPEUTICS INC (SABS)](/companies/sabs.md) | COM NEW | $5.9m | 0.3% | 1,525,000 |  | Added +950,000 |
| [MACROGENICS INC (MGNX)](/companies/mgnx.md) | COM | $5.6m | 0.3% | 1,216,606 |  | Added +716,606 |
| CRISPR THERAPEUTICS AG | NAMEN AKT | $5.5m | 0.2% | 100,000 |  | Reduced −50,000 |
| NEWAMSTERDAM PHARMA COMPANY | \*W EXP 99/99/999 | $5.3m | 0.2% | 245,000 |  | Unchanged |
| [ASSEMBLY BIOSCIENCES INC (ASMB)](/companies/asmb.md) | COM NEW | $5.2m | 0.2% | 190,000 |  | New +190,000 |
| [REZOLUTE INC (RZLT)](/companies/rzlt.md) | COM NEW | $5.2m | 0.2% | 1,000,000 |  | Reduced −547,641 |
| [PRECISION BIOSCIENCES INC (DTIL)](/companies/dtil.md) | COM NEW | $5.1m | 0.2% | 646,576 |  | Added +48,630 |
| [HEMAB THERAPEUTICS HLDGS INC (COAG)](/companies/coag.md) | COM SHS | $5.1m | 0.2% | 138,030 |  | New +138,030 |
| [VIRIDIAN THERAPEUTICS INC (VRDN)](/companies/vrdn.md) | COM | $4.6m | 0.2% | 250,000 |  | Unchanged |
| [ARRIVENT BIOPHARMA INC (AVBP)](/companies/avbp.md) | COM | $4.3m | 0.2% | 125,000 |  | Reduced −50,000 |
| [VERRICA PHARMACEUTICALS INC (VRCA)](/companies/vrca.md) | COM SHS | $4.3m | 0.2% | 707,338 |  | Unchanged |
| [COMPASS PATHWAYS PLC (CMPS)](/companies/cmps.md) | SPONSORED ADS | $4.3m | 0.2% | 301,183 |  | Reduced −807,300 |
| [MBX BIOSCIENCES INC (MBX)](/companies/mbx.md) | COM | $4.1m | 0.2% | 75,000 |  | Reduced −75,000 |
| RESEARCH ALLIANCE CORP III | ORD SHS CL A | $4.0m | 0.2% | 370,000 |  | New +370,000 |
| [IMMUNOVANT INC (IMVT)](/companies/imvt.md) | COM | $3.9m | 0.2% | 100,000 |  | Unchanged |
| AMANAT ACQUISITION CORP | CL A ORD | $3.8m | 0.2% | 375,000 |  | New +375,000 |
| BIOHAVEN LTD | COM | $3.7m | 0.2% | 250,000 |  | New +250,000 |
| [FAETH THERAPEUTICS INC (FTH)](/companies/fth.md) | COM NEW | $3.6m | 0.2% | 144,404 |  | New +144,404 |
| [KARYOPHARM THERAPEUTICS INC (KPTI)](/companies/kpti.md) | COM NEW | $3.1m | 0.1% | 312,500 |  | Reduced −187,500 |
| [ALECTOR INC (ALEC)](/companies/alec.md) | COM | $3.0m | 0.1% | 1,510,000 |  | Added +1,010,000 |
| [SPYGLASS PHARMA INC (SGP)](/companies/sgp.md) | COM SHS | $2.9m | 0.1% | 131,586 |  | Reduced −118,414 |
| CRINETICS PHARMACEUTICALS IN | COM | $2.8m | 0.1% | 75,000 |  | Unchanged |
| OAKTREE ACQUISITION CORP III | UNIT 10/04/2029 | $2.8m | 0.1% | 250,000 |  | Unchanged |
| CELCUITY INC | NOTE 0.250% 8/0 | $2.3m | 0.1% | $2,000,000 principal |  | New +2,000,000 |
| JATT II ACQUISITION CORP | ORD SHS | $2.3m | 0.1% | 200,000 |  | New +200,000 |
| [NEUMORA THERAPEUTICS INC. (NMRA)](/companies/nmra.md) | COM | $1.8m | <0.1% | 1,070,651 |  | New +1,070,651 |
| [AMYLYX PHARMACEUTICALS INC (AMLX)](/companies/amlx.md) | COM | $1.8m | <0.1% | 98,999 |  | New +98,999 |
| [ADLAI NORTYE LTD (ANL)](/companies/anl.md) | SPONSORED ADS | $1.8m | <0.1% | 153,847 |  | Reduced −10,901 |
| [SPRUCE BIOSCIENCES INC (SPRB)](/companies/sprb.md) | COM NEW | $1.6m | <0.1% | 30,000 |  | New +30,000 |
| [SUMMIT THERAPEUTICS INC (SMMT)](/companies/smmt.md) | COM | $1.5m | <0.1% | 100,000 | Call | New +100,000 |
| [EIKON THERAPEUTICS INC (EIKN)](/companies/eikn.md) | COM | $1.3m | <0.1% | 98,001 |  | New +98,001 |
| [ONKURE THERAPEUTICS INC (OKUR)](/companies/okur.md) | COM CL A | $1.1m | <0.1% | 240,963 |  | Unchanged |
| [ENGENE THERAPEUTICS INC (ENGN)](/companies/engn.md) | COM | $1.0m | <0.1% | 600,000 |  | New +600,000 |
| [X4 PHARMACEUTICALS INC (XFOR)](/companies/xfor.md) | COM NEW | $677.1k | <0.1% | 145,000 |  | Unchanged |
| [BOUNDLESS BIO INC (BOLD)](/companies/bold.md) | COM | $625.0k | <0.1% | 250,000 |  | New +250,000 |
| [LENZ THERAPEUTICS INC (LENZ)](/companies/lenz.md) | COM | $568.0k | <0.1% | 100,000 |  | Unchanged |
| [Q32 BIO INC (QTTB)](/companies/qttb.md) | COM | $353.9k | <0.1% | 27,777 |  | Unchanged |
| [ORCHESTRA BIOMED HLDGS INC (OBIO)](/companies/obio.md) | COM | $144.1k | <0.1% | 33,400 |  | Reduced −369,150 |
| [NEXTCURE INC (NXTC)](/companies/nxtc.md) | COM NEW | $67.1k | <0.1% | 41,960 |  | Reduced −199,866 |
| [ADAGIO MED HLDGS INC (ADGM)](/companies/adgm.md) | COM | $52.1k | <0.1% | 80,000 |  | Unchanged |
| ROCKET PHARMACEUTICALS INC | \*W EXP 09/02/202 | $278 | <0.1% | 75,000 |  | Unchanged |

## Sold out

Held at the end of the quarter before and not reported this quarter.

| Issuer | Class | Reported value | Weight | Shares | Put or call | Change on the quarter before |
| --- | --- | ---: | ---: | ---: | --- | --- |
| ARCELLX INC | COMMON STOCK | $0 | 0.0% | 0 |  | Sold out −362,764 |
| ASCENDIS PHARMA A/S | SPONSORED ADR | $0 | 0.0% | 0 |  | Sold out −95,000 |
| [BRIDGEBIO PHARMA INC (BBIO)](/companies/bbio.md) | COM | $0 | 0.0% | 0 |  | Sold out −150,000 |
| [BRISTOL-MYERS SQUIBB CO (BMY)](/companies/bmy.md) | COM | $0 | 0.0% | 0 | Call | Sold out −300,000 |
| [CELCUITY INC (CELC)](/companies/celc.md) | COM | $0 | 0.0% | 0 | Call | Sold out −30,000 |
| CELCUITY INC | NOTE 2.750% 8/0 | $0 | 0.0% | $0 principal |  | Sold out −3,000,000 |
| CENTESSA PHARMACEUTICALS PLC | SPONSORED ADS | $0 | 0.0% | 0 |  | Sold out −1,400,000 |
| [CG ONCOLOGY INC (CGON)](/companies/cgon.md) | COM | $0 | 0.0% | 0 | Call | Sold out −60,000 |
| [CORCEPT THERAPEUTICS INC (CORT)](/companies/cort.md) | COM | $0 | 0.0% | 0 |  | Sold out −50,000 |
| [DIANTHUS THERAPEUTICS INC (DNTH)](/companies/dnth.md) | COM | $0 | 0.0% | 0 | Call | Sold out −50,000 |
| ENGENE HOLDINGS INC | COM | $0 | 0.0% | 0 |  | Sold out −610,370 |
| [IMMUNITYBIO INC (IBRX)](/companies/ibrx.md) | COM | $0 | 0.0% | 0 | Put | Sold out −1,250,000 |
| KEZAR LIFE SCIENCES INC | COM NEW | $0 | 0.0% | 0 |  | Sold out −229,076 |
| [NOVO-NORDISK A S (NVO)](/companies/nvo.md) | ADR | $0 | 0.0% | 0 | Call | Sold out −175,000 |
| [REVOLUTION MEDICINES INC (RVMD)](/companies/rvmd.md) | COM | $0 | 0.0% | 0 | Put | Sold out −100,000 |
| [STATE STR SPDR S&P 500 ETF T (SPY)](/companies/spy.md) | TR UNIT | $0 | 0.0% | 0 | Put | Sold out −200,000 |
| TERNS PHARMACEUTICALS INC | COM | $0 | 0.0% | 0 |  | Sold out −562,631 |
| WAVE LIFE SCIENCES LTD | SHS | $0 | 0.0% | 0 |  | Sold out −1,401,727 |

Source: SEC EDGAR, Form 13F-HR, accession 0001011438-26-000516. Last ingested by Listed: Oct 22, 2026, 05:26 ET. No prices; not investment advice.